Effects of picotesla flux electromagnetic fields on dopaminergic transmission in tourette's syndrome

International Journal of Neuroscience

Volumn 84, Issue 1-4, 1996, Pages 187-194

  Sandyk, Reuven ^a,b,c  

^a NeuroCommunication Res Laboratories   (United States)

^b TOURO COLLEGE   (United States)

^c NONE   (United States)

Author keywords

Apomorphine; Dopamine autoreceptors; Electromagnetic fields; Motor tics; Postsynaptic D2 receptors; Tourette's syndrome; Yawning

Indexed keywords

DOPAMINE;

ELECTROMAGNETIC FIELD; GILLES DE LA TOURETTE SYNDROME; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; REVIEW; SYNAPTIC TRANSMISSION;

DOPAMINE; ELECTROMAGNETIC FIELDS; HUMANS; SYNAPTIC TRANSMISSION; TOURETTE SYNDROME;

EID: 0030077672     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459608987264     Document Type: Article

References (85)

1. Aghajanian, G. K. & Bunney, B. S. (1974). Pre-'and postsynaptic feedback mechanisms in central dopaminergic neurons. In P. Seeman & B. M. Brown (Eds.), Frotierns in neurology and neuroscience research: first international symposium of the neuroscience institute (pp. 4-11). University of Toronto: Toronto.
2. Bawin, S. M. & Adey, W. R. (1976). Sensitivity of calcium binding in cerebral tissue to weak environmental electrical fields oscillating at low frequency. Proceedings of the National Academy of Sciences USA, 73, 1999-2003.
3. Berendsen, H. H. G. & Nickolson, V. J. (1981). Androgenic influences on apomorphine-induced yawning in rats. Behavioral and Neural Biology, 33, 123-128.
4. Bertolini, A. & Gessa, G. L. (1981). Behavioral effects of ACTH and MSH peptides. Journal of Endocrinological Investigation. 4, 241-251.
5. Blackman, C. R, Shawnee, B. G., Kinney, L. S., Joines, W. T. & House, D. E. (1982). Effects of ELF fields on calcium-ion efflux from brain tissue in vitro. Radiation Research, 92, 510-520.
6. Bradbury, A. J., Kelly, M. E. & Smith, J. A. (1985). Melatonin action in the midbrain can regulate forebrain dopamine function both behaviourally and biochemically. In: G. M. Brown & S. D. Wainwright (Eds.), The Pineal Gland: Endocrine Aspects (pp. 327-332). Oxford: Pergamon Press.
7. Bruun, R. D. (1984). Gilles de la Tourette's syndrome. An overview of clinical experience. Journal of the American Academy of Child Psychiatry, 23, 126-133.
8. Burd, L. & Kerbeshian, J. (1984). Tourette syndrome and bipolar disorder. Archives of Neurology, 41, 1236.
9. Burton, S., Daya, S. & Potgieter, B. (1991). Melatonin modulates apomorphine-induced rotational behaviour. Experientia, 47, 466-469.
10. Butler, I. J., Koslow, S. H., Seifert, W. E., Caprioli, R. & Singer, H. S. (1979). Biogenic amine metabolism in Tourette's syndrome. Annals of Neurology, 6, 37-39.
11. Caine, E. D. (1985). Gilles de la Tourette's syndrome: a review of clinical and research studies and consideration of future directions for investigation. Archives of Neurology, 42, 393-397.
12. Carlsson, A. (1975). Receptor mediated control of dopamine metabolism. In E. Usdin & W. E. Bunney (Eds.), Pre- and postsynaptic receptors (pp. 49-63). New York: Marcel Dekker.
13. Choi, R. L. & Roth, R. H. (1978). Development of supersensitivity of apomorphine-induced increase in acetylcholine levels and stereotypy after chronic fluphenazine treatment. Neuropharmacology, 17, 59-64.
14. Comings, D. E. (1990). Tourette syndrome and human behavior (p. 399). Duarte, CA: Hope Press.
15. 2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232. Physiology & Behavior, 45, 1263-1266.
16. Cooper, J. R., Bloom, F. E. & Roth, R. H. (1991). The biochemical basis of neuropharmacology (pp. 304-319). New York: Oxford University Press.
17. Corsini, G. U., Del Zompo, M., Manconi, S., Piccardi, M. P., Onali, P. L. & Manconi, A. (1977). Evidence for dopamine receptors in the human brain mediating sedation and sleep. Life Sciences, 20, 1613-1618.
18. Cotzias, G. C., Tang, L. C, Miller, S. T. & Ginos, J. Z. (1971). Melatonin and abnormal movement induced by L-dopa in mice. Science, 173, 450-452.
19. Cummings, J. L. & Frankel, M. (1985). Gilles de la Tourette syndrome and the neurological basis of obsessions and compulsions. Biological Psychiatry, 20, 1117-1126.
20. Diamond, B. I. & Borison, R. L. (1978). Enkephalins and nigrostriatal function. Neurology, 28, 1085-1088.
21. Di Chiara, G., Corsini, G. U., Mereu, G. P., Tissari, A. & Gessa, G. L. (1978). Self-inhibitory dopamine receptors: their role in the biochemical and behavioural effects of low doses of apomorphine. In P. J. Roberts (Ed.), Advances in biochemicalpsychopharmacology (p. 275). New York: Raven Press.
22. Dourish, C. T. & Cooper, S. J. (1985). Behavioral evidence for the existence of dopamine autoreceptors. Trends in Pharmacological Sciences, 6, 17-23.
23. Dourish, C. T., Cooper, S. & Philips, S. (1985). Yawning elicited by systemic and intrastriatal injection of pirebedil and apomorphine in the rat. Psychopharmacology, 86, 175-181.
24. Dubuc, I., Protais, P., Colboc, O. & Contestin, J. (1982). Antagonism of the apomorphine-induced yawning by "atyical" neuroleptics. Neuropharmacology, 21, 1203-1206.
25. Feinberg, M. & Carroll, B. J. (1979). Effects of dopamine agonists and antagonists in Tourette's disease. Archives of General Psychiatry, 36, 979-985.
26. Goetz, C. G. (1986). Tics: Gilles de la Tourette's syndrome. In P. J. Vinken, G. W. Bruyn & H. L. Klawans (Eds.), Handbook of clinical neurology: extrapyramidal disorders, vol. 5, (pp. 627-639). Amsterdam: Elsevier Publishers.
27. Gower, A. J., Berendsen, H. H. G., Princen, M. M. & Brockkamp, C. L. E. (1984). The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity. European Journal of Pharmacology, 103, 81-89.
28. Grigoriadis, D. & Seeman, P. (1984). The dopamine/neuroleptic receptor. Canadian Journal of Neurological Sciences, 11, 108-113.
29. Groves, P. M., Wilson, C. J., Young, S. J. & Rebec, G. V. (1975). Self-inhibition of dopaminergic neurons: an alternative to the "neuronal feedback loop" hypothesis for the mode of action of certain psychotropic drugs. Science, 190, 522-529.
30. Haber, S. N., Kowall, N. W., Vonsattel, J. P., Bird, E. D. & Richardson, E. P. (1986). Gilles de la Tourette's syndrome: A postmortem neuropathological and immunohistochemical study. Journal of the Neurological Sciences, 75, 225-241.
31. Helmreich, I., Reimann, W., Hertting, G. & Starke, K. (1982). Are presynaptic dopamine autoreceptors and post-synaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different? Neuroscience, 6, 1559-1566.
32. Hornykiewicz, O. & Kish, S. J. (1990). Biochemical pathophysiology of Parkinson's disease. In M. D. Yahr & K. J. Bergmann (Eds.), Advances in neurology vol. 45 (pp. 19-34). New York: Raven Press.
33. Jagger, J., Prusoff, B. A., Cohen, D. J., Kidd, K. K., Carbonari, C. M. & John, K. (1982). The epidemiology of Tourette's syndrome: A pilot study. Schizophrenia Bulletin, 8, 267-278
34. Jankovic, J. & Rohaidy, H. (1987). Motor, beavioral and pharmacologic findings in Tourette's syndrome. Canadian Journal of Neurological Sciences, 14, 541-546.
35. Jankovic, J., Glaze, D. G. & Frost, J. D. (1984). Effect of tetrabenazine on tics and sleep of Gilles de la Tourelle syndrome. Neurology, 34, 688-692.
36. Jellinger, K. (1986). Pathology of Parkinsonism. In S. Fahn, C. D. Marsden, P. Jenner & P. Teychenne (Eds.), Recent developments in parkinson's disease (pp. 33-66). New York: Raven Press.
37. Karson, C. N., Berman, K. F., Kleinman, J. & Karoum, F. (1984). Seasonal variation in human central dopamine activity. Psychiatry Research, 11, 111-117.
38. Kavaliers, M. & Ossenkopp, K. P. (1992). Magnetic fields, opioid systems, and day-night rhythms of behavior. In M. C. Moore-Ede, S. S. Campbell & R. J. Reiter (Eds.), Electromagnetic fields and circadian rhythmicity (pp. 95-117). Boston: Birkhauser.
39. Laping, N. J. & Ramirez, V. D. (1988). Prolactin-induced yawning behavior requires an intact nigro-striatal dopamine system. Pharmacology Biochemistry & Behavior, 29, 59-62.
40. Leckman, J. F. & Cohen, D. J. (1983). Recent advances in Gilles de la Tourette's syndrome: Implications for clinical practice and future research. Psychiatric Developments, 3, 301-316.
41. Lehmam, J., Briley, Z. & Langer, S. Z. (1983). Characterisation of dopamine autoreceptors and 3H-spiperone binding sites in vitro with classical and novel dopamine receptor agonist. European Journal of Pharmacology, 88, 11-26.
42. Melis, M. R., Argiolas, A. & Gessa, G. L. (1986). Oxytocin-induced penile erection and yawning: site of action in the brain. Brain Research, 398, 259-264.
43. Messiha, F. S. (1988). Biochemical Pharmacology of Gilles de la Tourette's syndrome. Neuroscience & Biobehavioral Reviews, 12, 295-305.
44. Messiha, F. S, & Carlson, J. C. (1983). Behavioral and clinical profiles of Tourette's syndrome: A comprehen-sive overview. Brain Research Bulletin, 11, 195-204.
45. Mogilnicka, E. & Klimek, V. (1977). Drugs affecting dopamine neurons and yawning behavior. Pharmacology Biochemistry & Behavior, 7, 303-305.
46. Mogilnicka, E., Boissard, C. G. & Delini-Stula, A. (1984). Effecls of apomorphine, TL-99 and 3-PPP on yawning in rats. Neuropharmacology, 23, 19-22.
47. Mora, S. & Diaz-Veliz, G. (1989). LHRH antagonizes yawning and genital grooming induced by apomorphine in rats. Pharmacology Biochemistry & Behavior, 31, 717-720.
48. Nickolson, V. J. & Berendsen, H. H. G. (1980). Effecls of the potential neuroleptic peptide Des-tyr-y-endorphin and haloperidol on apomorphine-induced behavioral syndrome in rats and mice. Life Sciences, 27, 1377-1385.
49. Nowycky, M. C. & Roth, R. H. (1977). Presynaptic dopamine receptors: developmenl of supersensitivity following treatment with fluphenazine decanoate. Naunyn-Schmiedeberg's Archives of Pharmacology, 300, 247-254.
50. O'Donohue, T. L. & Dorsa, D. M. (1982). The opiomelanotrophinergic neuronal and endocrine systems. Peptides, 3, 353-395.
51. Olianas, M., De Montis, C., Mulas, G. M. & Tagliamonte, A. (1978). The striatal dopaminergic function is mediated by the inhibition of a nigral, nondopaminergic neuronal system via a strio-nigral GABA-ergic pathway. Eurtopean Journal of Pharmacology, 49, 233-241.
52. Protais, P., Dubuc, I. & Contestin, J. (1983). Pharmacolgical characteristics of dopamine receptors involved in the ral dual effect of dopamine agonists on yawning behavior in rats. European Journal of Pharmacology, 94, 271-277.
53. Richelson, E. (1994). Pharmacology of antidepressants-characteristics of the ideal drug. Mayo Clinic Proceedings, 69, 1069-1081.
54. Rinne, U. K., Rinne, J. O., Rinne, J. K., Laakso, K., Laihinen, A. & Lonnberg, P. (1983). Brain receptor changes in Parkinson's disease in relation to the disease process and treatment. Journal of Neural Transmission, 18 (suppl), 279-286.
55. Roberts, D. C. S., Zis, A. P. & Fibiger, H. C. (1975). Ascending catecholamine pathways and amphetamine-induced locomotor activity. Importance of dopamine and apparent non-involvement of norepinephrine. Brain Research. 93, 441-454.
56. Rosen, A. D. & Lubowsky, J. (1987). Magnetic fields influence on central nervous system function. Experimental Neurology, 95, 679-687.
57. Sandyk, R. (1988). Clomiphene citrate in Tourette's syndrome. International Journal of Neuroscience. 43, 103-106.
58. Sandyk, R. (1989 a). Abnormal opiate receptor functions in Tourette's syndrome. International Journal of Neuroscience, 44, 209-214.
59. Sandyk, R. (1989 b). Abnormal opiate receptor functions in Tourette's syndrome. International Journal of Neuroscience, 44, 209-214.
60. Sandyk, R. (1992 a). Weak magnetic fields as a novel therapeutic modality in Parkinson's disease. International Journal of Neuroscience, 66, 1-15.
61. Sandyk, R. (1992 b). Magnetic fields in the therapy of parkinsonism. International Journal of Neuroscience, 66, 209-235.
62. Sandyk, R. (1994). A drug naive Parkinsonian patient successfully treated with electromagnetic fields. International Journal of Neuroscience, 79, 99-110.
63. Sandyk, R. (1995). Cholinergic mechanisms in Gilles de la Tourette's syndrome. International Journal of Neuroscience, 81, 95-100.
64. Sandyk, R. & Bamford, C. R. (1988). Fluctuations of symptoms during manic-depressive mood changes in Tourette's syndrome. Journal of Clinical Psychopharmacology, 8, 149.
65. Sandyk, R., Iacono, R. P. & Bamford, C. R. (1987). Menstrual-related fluctuations in Tourette's syndrome. Neurology, 37 (suppl), 276.
66. Sandyk, R., Bamford, C. R., Binkiewicz, A. & Finley, P. R. (1988 a). Gonadotrophin deficiency in Tourette's syndrome. A preliminary communication. International Journal of Neuroscience, 42, 121-125.
67. Sandyk, R., Bamford, C. R. & Iacono, R. P. (1988 b). Sexual hormones in the pathophysiology of Tourette's syndrome. International Journal of Neuroscience, 38, 125-129.
68. Sandyk, R. & Derpapas, K. (1993). Further observations on the unique efficacy of picotesla magnetic fields in Parkinson's disease. International Journal of Neuroscience, 69, 167-183.
69. Seeger, T. F., Nazzaro, J. M. & Gardner, E. L. (1980). Selective inhibition of mesolimbic behavioral supersensitivity by naloxone. European Journal of Pharmacology, 65, 435-438.
70. Seeman, M. V., Patel, J. & Pyke, J. (1981). Tardive dyskinesia with Tourette-like syndrome. Journal of Clinical Psychiatry, 42, 357-358.
71. Semm, P. (1983). Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology, 76A, 683-689.
72. Serra, G., Collu, M., Loddo, S., Celasco, G. & Gessa, G. L. (1983). Hypophysectomy prevents yawning and penile erection but not hypomotility induced by apomorphine. Pharmacology Biochemistry & Behavior, 19, 917-919.
73. Serra, G., Collu, M., Serra, A. & Gessa, G. L. (1984). Estrogens antagonize apomorphine-induced yawning in rats. European Journal of Pharmacology, 104, 383-386.
74. Serra, G., Collu, M. & Gessa, G. L. (1986). Dopamine receptor mediated yawning: are they autoreceptors? European Journal of Pharmacology, 120, 187-192.
75. Severson, J. & Finch, C. (1980). Reduced dopaminergic binding during aging in the rodent striatum. Brain Research, 192, 147-162.
76. Singer, H. S., Butler, I. J., Tune, L. E., Seifert, W. E. & Coyle, J. T. (1982). Dopaminergic dysfunction in Tourette syndrome. Annals of Neurology, 12, 361-366.
77. Staehle, L. & Ungerstedt, U. (1984). Assessment of dopamine autoreceptor agonist properties of apomorphine, (+) 3PPP and (-) 3PPP by recording of yawning behaviour in rats. European Journal of Pharmacology, 98, 307-310.
78. Stahl, S. M. & Berger, P. A. (1982). Neuroleptic effect in Tourette syndrome predict dopamine excess and acetylcholine deficiency. Biological Psychiatry, 17, 1047-1053.
79. Stoessl, A., Martin-Iverson, M., Barth, T., Dourish, C. & Iverson, S. (1989). Effects of aging on the behavioral response to dopamine agonists decreased yawning and locomotion, but increased stereotypy. Brain Research, 495, 20-30.
80. Stoupel, E., Keret, R., Assa, S., Kaufman, H., Shimshoni, M., & Laron, Z. (1983). Secretion of growth hormone, prolactin and corticosteroids during different levels of geomagnetic activity. Neuroendocrinology Letters, 5, 365-368.
81. Szechtman, H., Cleghorn, J. M., Brown, G. M., Kaplan, R. D., Franco, S., & Rosenthal, K. (1988). Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea and hyperthermia. Psychiatry Research, 23, 245-255.
82. Walters, J. & Roth, R. (1976). Dopaminergic neurons: An in vivo system for measuring drug interaction with presynaptic receptors. Naunyn-Schmiedeberg's Archives of Pharmacology, 296, 5-14.
83. Welker, H. A., Semm, P., Willig, R. P., Commentz, J. C., Wiltschko, W. & Vollrath, L. (1983). Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research, 50, 426-432.
84. Yamada, K. & Furukawa, T. (1979). Effects of fluphenazine and its metabolite on dopaminergic neurons with special relation to catalepsy and yawning. Folia Pharmacologia (Japan), 75, 7IP.
85. Yamada, K. & Furukawa, T. (1980). Direct evidence for involvement of dopaminergic inhibition and cholinergic activation of yawning. Psychopharmacology, 67, 39-43.